These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
394 related items for PubMed ID: 20417473
41. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry. Giannini S, Mezzasoma AM, Leone M, Gresele P. Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988 [Abstract] [Full Text] [Related]
42. Diagnosis and management of von Willebrand disease in Iran. Cohan N, Karimi M. Semin Thromb Hemost; 2011 Jul; 37(5):602-6. PubMed ID: 22102206 [Abstract] [Full Text] [Related]
43. Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease. Lubetsky A, Schulman S, Varon D, Martinowitz U, Kenet G, Gitel S, Inbal A. Thromb Haemost; 1999 Feb; 81(2):229-33. PubMed ID: 10063997 [Abstract] [Full Text] [Related]
44. Diagnosis and management of von Willebrand disease: guidelines for primary care. Yawn B, Nichols WL, Rick ME. Am Fam Physician; 2009 Dec 01; 80(11):1261-8. PubMed ID: 19961139 [Abstract] [Full Text] [Related]
47. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications. Michiels JJ, van de Velde A, van Vliet HH, van der Planken M, Schroyens W, Berneman Z. Semin Thromb Hemost; 2002 Apr 01; 28(2):111-32. PubMed ID: 11992235 [Abstract] [Full Text] [Related]
52. [Von Willebrand disease: characteristics and response to desmopressin. Study of 103 cases]. César JM, Avello AG, Vecino A, Cerveró C, Laraña JG, Fuertes IF, Villarrubia J, López J, de Oteyza JP, Velasco JL, Cantalapiedra A, Herrera P, Herrero S, Navarro JL. Med Clin (Barc); 1998 Nov 14; 111(16):601-3. PubMed ID: 9881332 [Abstract] [Full Text] [Related]
53. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1. Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z. Acta Haematol; 2009 Nov 14; 121(2-3):119-27. PubMed ID: 19506358 [Abstract] [Full Text] [Related]
55. Haemostatic management of intraoral bleeding in patients with von Willebrand disease. Morimoto Y, Yoshioka A, Sugimoto M, Imai Y, Kirita T. Oral Dis; 2005 Jul 14; 11(4):243-8. PubMed ID: 15984956 [Abstract] [Full Text] [Related]
58. Update on the management of von Willebrand disease. Federici AB. Clin Adv Hematol Oncol; 2008 Jan 14; 6(1):29-30. PubMed ID: 18322438 [No Abstract] [Full Text] [Related]
59. Precise diagnosis by gene analysis and successful management of delivery in three patients with type IIB von Willebrand disease. Takafuta T, Fujimura K, Shimomura T, Kawano H, Takimoto Y, Fujimoto T, Nagai N, Okamoto E, Ohama K, Nakamura K. Int J Hematol; 1994 Aug 14; 60(2):163-72. PubMed ID: 7948966 [Abstract] [Full Text] [Related]
60. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD. Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van de Velde A, van Vliet H. Clin Appl Thromb Hemost; 2006 Jul 14; 12(3):277-95. PubMed ID: 16959681 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]